ROSEN, A TOP RANKED LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXLNewsfile Corp • 04/01/22
Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease SummitGlobeNewsWire • 03/28/22
Anavex's Blarcamesine And Cassava Sciences' Simufilam: The Stabilization Period For Alzheimer's DiseaseSeeking Alpha • 03/23/22
Anavex Life Sciences Corp. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the FirmNewsfile Corp • 03/21/22
ROSEN, A LEADING LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXLPRNewsWire • 03/16/22
Anavex Life Sciences Highlights Biomarker Data From Parkinson's Disease Dementia At International ConferenceBenzinga • 03/15/22
Anavex Life Sciences to Participate in the Annual Needham Virtual Neuroscience ForumGlobeNewsWire • 03/09/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of InvestorsBusiness Wire • 03/08/22
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXLPRNewsWire • 03/07/22
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of InvestorsBusiness Wire • 03/07/22
The Law Offices of Frank R. Cruz Continues Its Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of InvestorsBusiness Wire • 03/07/22
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Anavex Life Sciences Corp. Investors with Losses to Inquire About Securities Class Action Investigation - AVXLNewsfile Corp • 02/23/22
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXLPRNewsWire • 02/18/22
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXLNewsfile Corp • 02/16/22
Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/10/22
AVXL INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors with Losses to Inquire About Securities Class Action Investigation - AVXLPRNewsWire • 02/10/22
Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 02/09/22
Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 First Quarter Financial ResultsGlobeNewsWire • 02/09/22
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/04/22
Anavex Life Sciences Provides Supplemental Information on ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial for the Treatment of Adult Patients with Rett SyndromeGlobeNewsWire • 02/04/22
Investigation Notice: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/03/22
Anavex Life Sciences to Announce Fiscal 2022 First Quarter Financial Results on Wednesday, February 9, 2022GlobeNewsWire • 02/03/22
ANAVEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Anavex Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 02/03/22
